Cytokine plasma levels: reliable predictors for radiation pneumonitis?
<h4>Background</h4>Radiotherapy (RT) is the primary treatment modality for inoperable, locally advanced non-small-cell lung cancer (NSCLC), but even with highly conformal treatment planning, radiation pneumonitis (RP) remains the most serious, dose-limiting complication. Previous clinica...
Guardado en:
Autores principales: | Claudia E Rübe, Jan Palm, Michael Erren, Jochen Fleckenstein, Jochem König, Klaus Remberger, Christian Rübe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2fbaec7801824f0391e82b1e8577df47 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DNA-damage foci to detect and characterize DNA repair alterations in children treated for pediatric malignancies.
por: Nadine Schuler, et al.
Publicado: (2014) - Pneumon
-
Biological dosiomic features for the prediction of radiation pneumonitis in esophageal cancer patients
por: Chanon Puttanawarut, et al.
Publicado: (2021) -
A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation
por: Shi HS, et al.
Publicado: (2012) -
Pulmonary emphysema is a risk factor for radiation pneumonitis in NSCLC patients with squamous cell carcinoma after thoracic radiation therapy
por: Ziyang Zhou, et al.
Publicado: (2017)